Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
Replaced content with " {| class="wikitable sortable" |+Gene-Specific Pages !'''Gene''' !'''Author''' !'''Date Assigned to Author''' !'''Target Completion Date''' !'''Author Content (Pending or..." Tags: Replaced Visual edit |
m Reverted edits by FQuintero (talk) to last revision by Malini.Sathanoori Tag: Rollback |
||
| Line 1: | Line 1: | ||
{| class="wikitable" | |||
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content | |||
|- | |||
!'''Disease'''!!'''Page Type'''!!'''Author''' | |||
!'''Date Assigned to Author''' | |||
!'''Target Completion Date''' | |||
!'''Author Content (Pending or Complete)''' | |||
!'''Date Completed by Author'''!!'''Associate Editor''' | |||
!'''Date of Last Editor Review''' | |||
!'''Notes''' | |||
|- | |||
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera | |||
| | |||
| | |||
|complete | |||
| | |||
|Fabiola Quintero-Rivera (FQR) | |||
| | |||
| | |||
|- | |||
| Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive||Disease | |||
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera | |||
| | |||
| | |||
|complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Chronic Neutrophilic Leukemia (CNL)||Disease | |||
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera | |||
| | |||
| | |||
|complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Polycythaemia Vera (PV)||Disease | |||
|Gokce A. Toruner | |||
| | |||
| | |||
|complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Primary Myelofibrosis (PMF)||Disease | |||
|T. Niroshi Senaratne | |||
| | |||
| | |||
|complete | |||
| | |||
|FQR | |||
|8/4/2020 before submission | |||
| | |||
|- | |||
| Essential Thrombocythaemia (ET)||Disease | |||
|Rebecca Smith (trainee) + Fabiola Quintero-Rivera | |||
| | |||
| | |||
|complete/pending faculty review | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Chronic Eosinophilic Leukemia, Not Otherwise Specified||Disease | |||
|(trainee), Daynna J.Wolff | |||
| | |||
| | |||
|PENDING | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Myeloproliferative Neoplasm (MPN), Unclassifiable||Disease | |||
|Thomas Lee | |||
|8/17/2020 | |||
|9/7/2020 | |||
|complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
|'''''Mastocytosis'''''||'''''Overview'''''||'''Shashi Shetty, Ph.D.''' | |||
| | |||
| | |||
|complete | |||
| ||FQR | |||
| | |||
| | |||
|- | |||
| Cutaneous Mastocytosis||Disease | |||
|Thuy Phung | |||
| | |||
|9/1/20 | |||
|PENDING | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Systemic Mastocytosis||Disease | |||
|Shashi Shetty | |||
| | |||
| | |||
|complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Mast Cell Sarcoma||Disease | |||
|Thuy Phung +Jordan Lowery | |||
| | |||
|9/1/20 | |||
|complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff | |||
| | |||
| | |||
|complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden (trainee) +Daynna J.Wolff | |||
| | |||
| | |||
|Complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff | |||
| | |||
| | |||
|Complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding | |||
| | |||
| | |||
|Complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Myeloid/Lymphoid Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff | |||
| | |||
| | |||
|Complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2 | |||
|Disease | |||
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff | |||
| | |||
| | |||
|Complete | |||
| | |||
|FQR | |||
| | |||
|NON-WHO ENTITY | |||
|- | |||
|Myeloid/Lymphoid Neoplasms with BCR-JAK2 | |||
|Disease | |||
|Lauren R. Crowson (trainee) + Daynna J. Wolff | |||
| | |||
| | |||
|Complete | |||
| | |||
|FQR | |||
| | |||
|NON-WHO ENTITY | |||
|- | |||
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang | |||
| | |||
| | |||
|Complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Chronic Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang | |||
| | |||
| | |||
|Complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang | |||
| | |||
| | |||
|Complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Juvenile Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo | |||
| | |||
|9/1/20 | |||
|PENDING | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera | |||
| | |||
| | |||
|complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon | |||
| | |||
| | |||
|complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek? | |||
| | |||
|9/1/20 | |||
|pending | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek | |||
| | |||
|9/1/20 | |||
|PENDING | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek | |||
| | |||
| | |||
|Complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek | |||
| | |||
| | |||
|Complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Myelodysplastic Syndrome (MDS) with Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek | |||
| | |||
|9/1/20 | |||
|PENDING | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Myelodysplastic Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek | |||
| | |||
|9/1/20 | |||
|PENDING | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Myelodysplastic Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek | |||
| | |||
| | |||
|Complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Myelodysplastic Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek | |||
| | |||
| | |||
|complete | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| Refractory Cytopenia of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek | |||
| | |||
|9/1/20 | |||
|PENDING | |||
| | |||
|FQR | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident) | |||
| | |||
| | |||
|Complete | |||
| | |||
|Jennelle Hodge (JH)/ Malini Sathanoori (MS) | |||
| | |||
| | |||
|- | |||
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying Zou | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
|01/19/2021-MS (re-review) | |||
| | |||
|- | |||
| Acute Myeloid Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident) | |||
| | |||
| | |||
|PENDING | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Myeloid Neoplasms with Germline DDX41 Mutation||Disease||Fei Yang | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
|02/01/2021-MS | |||
| | |||
|- | |||
| Myeloid Neoplasms with Germline RUNX1 Mutation||Disease||Malini Sathanoori | |||
| | |||
| | |||
|Complete | |||
|02/03/2021||JH / MS | |||
| | |||
| | |||
|- | |||
| Myeloid Neoplasms with Germline ANKRD26 Mutation||Disease||Fei Yang | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
|02/03/2021-MS | |||
| | |||
|- | |||
| Myeloid Neoplasms with Germline ETV6 Mutation||Disease||Ying Zou | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
|02/01/2021-MS (re-review) | |||
| | |||
|- | |||
| Myeloid Neoplasms with Germline GATA2 Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident) | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee) | |||
| | |||
| | |||
|Complete | |||
| | |||
|JH / MS | |||
| | |||
| | |||
|- | |||
| Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Acute Promyelocytic Leukemia (APL) with PML-RARA||Disease||Shashi Shetty | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
|Need permission for figure? Update WHO? | |||
|- | |||
| Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Acute Myeloid Leukemia (AML) with BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health) | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Acute Myeloid Leukemia (AML) with Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health) | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
|Add WHO reference | |||
|- | |||
| Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg Conboy (Monash Health) | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Acute Myeloid Leukemia (AML) with Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident) | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident) | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
|Check reference format | |||
|- | |||
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Acute Myeloid Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow) | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Acute Myelomonocytic Leukemia||Disease||Fei Yang | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Pure Erythroid Leukemia||Disease||Ash Yenamandra | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Acute Basophilic Leukemia||Disease||Ash Yenamandra | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow) | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty Greipp | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
|Need permission for figure? | |||
|- | |||
| Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome||Disease||Linda Cooley | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Myeloid Leukemia Associated with Down Syndrome||Disease||Linda Cooley | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident) | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Acute Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident) | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
|Check reference format | |||
|- | |||
| Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident) | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera | |||
| | |||
| | |||
|Complete | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types||Disease||Daynna Wolff+ Elicia Goodale (resident) | |||
| | |||
| | |||
|PENDING | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
| Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease||Daynna Wolff+Madison Hannay or Elicia Goodale (residents) | |||
| | |||
| | |||
|PENDING | |||
| ||JH / MS | |||
| | |||
| | |||
|- | |||
|Acute Myeloid Leukemia (AML) with Mutated FLT3 | |||
|Disease | |||
|Kay Weng Choy + Greg Conboy (Monash Health) | |||
| | |||
| | |||
|Complete | |||
| | |||
|JH / MS | |||
| | |||
|NON-WHO ENTITY | |||
|- | |||
|Acute Myeloid Leukemia (AML) with NUP214-ABL1 | |||
|Disease | |||
|Daynna Wolff+Jessica Snider (Path Resident) | |||
| | |||
| | |||
|PENDING | |||
| | |||
|JH / MS | |||
| | |||
|NON-WHO ENTITY | |||
|- | |||
|Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6 | |||
|Disease | |||
|Daynna Wolff+ Paige Woodham (Path Resident) | |||
| | |||
| | |||
|PENDING | |||
| | |||
|JH / MS | |||
| | |||
|NON-WHO ENTITY | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| ||Yassmine Akkari (YA) | |||
| | |||
| | |||
|- | |||
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| ||YA | |||
| | |||
| | |||
|- | |||
| B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 ||Disease||Afia Hasnain + Yassmine Akkari | |||
| | |||
| | |||
|PENDING | |||
| ||YA | |||
| | |||
| | |||
|- | |||
| B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee) | |||
| | |||
| | |||
|PENDING | |||
| | |||
|YA | |||
| | |||
| | |||
|- | |||
| B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari | |||
| | |||
| | |||
|PENDING | |||
| ||YA | |||
| | |||
| | |||
|- | |||
| B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari | |||
| | |||
| | |||
|PENDING | |||
| ||YA | |||
| | |||
| | |||
|- | |||
| B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy||Disease||Ashwini Yenamandra + | |||
Lisa Smith + Yassmine Akkari | |||
| | |||
| | |||
|Complete | |||
| | |||
|YA | |||
| | |||
| | |||
|- | |||
| B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley | |||
| | |||
| | |||
|PENDING | |||
| ||YA | |||
| | |||
| | |||
|- | |||
| B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley | |||
| | |||
| | |||
|PENDING | |||
| ||YA | |||
| | |||
| | |||
|- | |||
| B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera | |||
| | |||
| | |||
|Complete | |||
| | |||
|YA | |||
| | |||
| | |||
|- | |||
| B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease||Holli Drendel | |||
| | |||
| | |||
|PENDING | |||
| ||YA | |||
| | |||
| | |||
|- | |||
| B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease|| | |||
| | |||
| | |||
| | |||
| ||YA | |||
| | |||
| | |||
|- | |||
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| ||YA | |||
| | |||
| | |||
|- | |||
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| | |||
| | |||
| | |||
| | |||
| ||YA | |||
| | |||
| | |||
|- | |||
|NK-Lymphoblastic Leukemia/Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| ||YA | |||
| | |||
| | |||
|- | |||
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements | |||
|Disease | |||
|Helene Bruyere | |||
| | |||
| | |||
|PENDING | |||
| | |||
|YA | |||
| | |||
|NON-WHO ENTITY | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| ||Snehal Patel (SP) | |||
| | |||
| | |||
|- | |||
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Snehal Patel | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| Monoclonal B-cell Lymphocytosis||Disease||Snehal Patel | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
|B-cell Prolymphocytic Leukemia||Disease||Snehal Patel | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel | |||
| | |||
| | |||
|Complete | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
|Hairy Cell Leukemia||Disease||Snehal Patel | |||
| | |||
| | |||
|Complete | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel | |||
| | |||
| | |||
|Complete | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| Splenic Diffuse Red Pulp Small B-cell Lymphoma||Disease||Snehal Patel | |||
| | |||
| | |||
|Complete | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| Hairy Cell Leukemia Variant||Disease||Snehal Patel | |||
| | |||
| | |||
|Complete | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
|Lymphoplasmacytic Lymphoma||Disease||Snehal Patel | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| Waldenstrom Macroglobulinemia||Disease||Snehal Patel | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|'''''Heavy Chain Diseases'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
| Mu Heavy Chain Disease||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
| Gamma Heavy Chain Disease||Disease||Manisha Sutariya | |||
| | |||
| | |||
|PENDING | |||
| ||SP | |||
| | |||
| | |||
|- | |||
| Alpha Heavy Chain Disease||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|Plasma Cell Neoplasms||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| | |||
| | |||
| | |||
| | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee) | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| Plasmacytoma||Disease|| | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
|''''' Monoclonal Immunoglobulin Deposition Diseases'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
| Primary Amyloidosis||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
| Light Chain and Heavy Chain Deposition Disease||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
| POEMS Syndrome||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
| TEMPI Syndrome||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease|| | |||
| | |||
| | |||
| | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem | |||
| | |||
| | |||
|PENDING | |||
| ||SP | |||
| | |||
| | |||
|- | |||
| Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee) | |||
| | |||
| | |||
|Complete | |||
|11/11/2020 | |||
|SP | |||
| | |||
| | |||
|- | |||
|Follicular Lymphoma||Disease||Ruthann Pfau | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| Testicular Follicular Lymphoma||Disease||Ruthann Pfau | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| In Situ Follicular Neoplasia||Disease||Ruthann Pfau | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee) | |||
| | |||
| | |||
|Complete | |||
|8/16/2020 | |||
|SP | |||
| | |||
| | |||
|- | |||
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid | |||
| | |||
|9/30/20 | |||
|PENDING | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem | |||
| | |||
| | |||
|PENDING | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari | |||
| | |||
|8/15/20 | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| Leukemic Non-Nodal Mantle Cell Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| In Situ Mantle Cell Neoplasia||Disease|| | |||
| | |||
| | |||
| | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra | |||
| | |||
| | |||
|PENDING | |||
| | |||
|Greg Corboy (GC) | |||
| | |||
| | |||
|- | |||
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
|EBV-Positive Mucocutaneous Ulcer||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
|Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
| Fibrin-Associated Diffuse Large B-cell Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
|Lymphomatoid Granulomatosis||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
|Intravascular Large B-cell Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
|ALK-Positive Large B-cell Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera | |||
| | |||
| | |||
|Complete | |||
| ||GC | |||
| | |||
| | |||
|- | |||
|Primary Effusion Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
| Multicentric Castleman Disease||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
| HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
| HHV8-Positive Germinotropic Lymphoproliferative Disorder||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
|Burkitt Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
|Burkitt-Like Lymphoma with 11q Aberration||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
| High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
| High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
|B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| ||GC | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| ||Snehal Patel (SP) | |||
| | |||
| | |||
|- | |||
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don | |||
| | |||
| | |||
|PENDING | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don | |||
| | |||
| | |||
|PENDING | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don | |||
| | |||
| | |||
|PENDING | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|Aggressive NK-cell Leukemia||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
| Systemic EBV-Positive T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee) | |||
| | |||
| | |||
|PENDING | |||
| ||SP | |||
| | |||
| | |||
|- | |||
| Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
| Hydroa Vacciniforme-Like Lymphoproliferative Disorder||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
| Severe Mosquito Bite Allergy||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|Adult T-cell Leukemia/Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee) | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee) | |||
| | |||
| | |||
|Complete | |||
|1/21/2021 | |||
|SP | |||
| | |||
| | |||
|- | |||
| Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee) | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee) | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don | |||
| | |||
| | |||
|Complete | |||
|1/21/2021 | |||
|SP | |||
| | |||
| | |||
|- | |||
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee) | |||
| | |||
| | |||
|PENDING | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee) | |||
| | |||
| | |||
|PENDING | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
| Lymphomatoid Papulosis||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
| Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
| Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
| Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
| Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
| Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
| Angioimmunoblastic T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee) | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| Follicular T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee) | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg | |||
| | |||
| | |||
|PENDING | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| ||Associate Editor?? | |||
| | |||
| | |||
|- | |||
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| Nodular Sclerosis Classic Hodgkin Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| Mixed Cellularity Classic Hodgkin Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| Lymphocyte-Depleted Classic Hodgkin Lymphoma||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|Lymphomas Associated with HIV Infection||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| Non-Destructive Post-Transplant Lymphoproliferative Disorders||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| Polymorphic Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,'' | |||
Fabiola Quintero-Rivera | |||
| | |||
| | |||
|PENDING | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|''''' Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| Monomorphic B-cell PTLD||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| Monomorphic T/NK-cell PTLD||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|Histiocytic Sarcoma||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| Langerhans Cell Histiocytosis||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| Langerhans Cell Sarcoma||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|Indeterminate Dendritic Cell Tumour||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|Interdigitating Dendritic Cell Sarcoma||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|Follicular Dendritic Cell Sarcoma||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|Fibroblastic Reticular Cell Tumor||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|Disseminated Juvenile Xanthogranuloma||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
|Erdheim-Chester Disease||Disease|| | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|- | |||
| || || | |||
| | |||
| | |||
| | |||
| || | |||
| | |||
| | |||
|} | |||
{| class="wikitable sortable" | {| class="wikitable sortable" | ||
|+Gene-Specific Pages | |+Gene-Specific Pages | ||